Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

GLP-1 manufacturers are now offering significant discounts to entice payers and employers to cover their popular medications, The Wall Street Journal reported Sept. 20. In January, Eli Lilly launched ...

The CPG industry has been getting involved in GLP-1 popularity recently by prioritizing macros, mainly protein, in a wide range of products. But now a more targeted option opens itself up at the ...

Novo Nordisk, the Danish drug company that makes Ozempic and Wegovy, is now offering the drugs at lower prices for self-pay patients. On Monday, the company announced it would offer both medications, ...

As the early signs of GLP-1-driven disruption emerge in the food sector, more manufacturers are exploring weight management-friendly innovation. The shift isn’t seismic yet, but momentum is building.

GLP-1 drugs are predicted to completely disrupt food and beverage. While some CPGs hold back, waiting to see how suppressed appetites and curbed cravings will hit sales, others are leaning into the ...

GLP-1 manufacturers are now offering significant discounts to entice payers and employers to cover their popular medications, The Wall Street Journal reported Sept. 20. In January, Eli Lilly launched ...